States with legal recreational cannabis markets were less likely to report large numbers of e-cigarette or vaping-associated lung injury (EVALI) cases during the 2019 vaping crisis, a new study has found.
The new bill requires the state Department of Cannabis Control to appoint at least one cannabinoid test as the standard for state-certified labs by January 1, 2023.
To address this, two British ambulance services are now participating in a new trial to investigate whether ketamine injections may be a more effective relief treatment for severe injury pain than the current treatment options available to Britain’s first responders.
The study, which was published in the British Journal of Pharmacology, found that CBGA was the most potent of the three and may also affect many of the same therapeutic targets that are targeted by traditional anti-epilepsy drugs.
Published in the Journal of Clinical Pharmacology, the study surveyed the first group of UK chronic pain patients prescribed medical cannabis oil.
People with a history of cannabis use in their medical records appear to be at a higher risk for developing problems with anxiety, depression, and even more severe mental illnesses such as schizophrenia, according to a new study from researchers at the University of Birmingham.
Exposure to THC in the womb could increase the risk that genetically predisposed children are born with facial defects, according to a new rodent study published in the journal Development.
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.